A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor ...
GLP-1 receptor agonists — the drug class that includes Ozempic, Wegovy and Mounjaro — were linked to improved survival among colon cancer patients in a new observational study from UC San Diego.
At a White House event Thursday, President Trump announced deals with drug makers Novo Nordisk and Eli Lilly to offer their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback